Form 4: NHC Director Emil E. Hassan Receives Stock Option Grant
Statement of Changes in Beneficial Ownership
National HealthCare Corporation director Emil E. Hassan was granted 7,500 stock options as part of the company's 2020 Omnibus Equity Incentive Plan.
Summary
- Director Emil E. Hassan received a grant of 7,500 stock options for National HealthCare Corporation (NHC) common stock.
- The options were granted on May 7, 2026, with an exercise price of $171.42 per share.
- The options vest beginning May 7, 2027, and expire on May 6, 2031.
- The reporting person maintains direct ownership of 73,095 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- The grant aligns the director's long-term interests with those of shareholders through equity-based compensation.
Negatives
- The grant results in potential future dilution for existing shareholders upon the exercise of these options.
Risks
- The value of the granted options is subject to market volatility and the future performance of NHC common stock.
Future Outlook
The options vest on May 7, 2027, indicating a long-term retention strategy for the director.
Management Comments
- The grant of these stock options is pursuant to the 2020 Omnibus Equity Incentive Plan.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the healthcare services sector to ensure alignment with shareholder value creation.
Comparison to Industry Standards
- The use of an Omnibus Equity Incentive Plan is consistent with standard compensation practices for publicly traded healthcare companies.
- The vesting schedule and expiration terms are typical for executive and director compensation packages in the U.S. market.
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- The options will become exercisable on May 7, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/07/2026 | Date of grant for the 2026 stock options and date of filing. |
| 05/07/2027 | Date the 2026 stock options become exercisable. |
| 05/06/2031 | Expiration date of the 2026 stock options. |
Keywords
National HealthCare Corporation, NHC, Form 4, Insider Trading, Stock Options, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.